Abuse of Process Clarified by Canadian Federal Court of Appeal

June 26, 2009

Tags:

Advertising and Marketing Intellectual Property Intellectual Property Litigation Patents Pharmaceuticals

Related Expertise

Related Insights

Choueifaty: A “solution” to a “problem” for computer-implemented and medical diagnostic method inventions
COVID-19 triggers Canadian intellectual property deadline extensions until August 31, 2020
Indirect comparisons to an innovative drug’s data can trigger data protection provisions
Video: what does a new ruling on Canada’s equivalent to patent term extension mean for the pharmaceutical industry?
Data management: turning risk into opportunity

Back